Investigation of Metabolic Risk in Korean Adults

March 14, 2019 updated by: Soo Lim, Seoul National University Bundang Hospital
A cohort study with Korean adults to investigate biomarkers in prediction of cardiometabolic and other diseases

Study Overview

Status

Completed

Conditions

Detailed Description

This is a prospective cohort study with Korean adults to investigate biomarkers in prediction of cardiometabolic and other diseases

Study Type

Observational

Enrollment (Actual)

1003

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Korea, Republic of
    • Gyeonggi
      • Seongnam, Gyeonggi, Korea, Republic of, 463-707
        • Seoul National University Bundang Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Healthy Korean Adults

Description

Inclusion Criteria:

  • Healthy adults without chronic diseases
  • Diabetic patients who are well controlled with oral antidiabetic agents
  • Hypertensive patients who are well controlled with oral antihypertensive agents
  • Dyslipidemic patients who are well controlled with oral lipid-lowering agents

Exclusion Criteria:

  • Malignancy
  • Chronic wasting disease
  • Long-term steroid use

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Normal cohort
Normal cohort for biobank

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Incidence of cardiovascular disease
Time Frame: 5 years
5 years

Secondary Outcome Measures

Outcome Measure
Time Frame
Incidence of diabetes mellitus
Time Frame: 5 years
5 years
Incidence of fatty liver
Time Frame: 5 years
5 years
Incidence of metabolic syndrome
Time Frame: 5 years
5 years
Incidence of osteoporosis
Time Frame: 5 years
5 years
Incidence of sarcopenia
Time Frame: 5 years
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Seoul National University Bundang Hospital

Investigators

  • Principal Investigator: Soo Lim, MD, PhD, SNUBH

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2015

Primary Completion (Actual)

November 30, 2018

Study Completion (Actual)

February 28, 2019

Study Registration Dates

First Submitted

December 19, 2015

First Submitted That Met QC Criteria

December 22, 2015

First Posted (Estimate)

December 29, 2015

Study Record Updates

Last Update Posted (Actual)

March 15, 2019

Last Update Submitted That Met QC Criteria

March 14, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SNUBH-Biobank

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Disease

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe